Feng-Yi Ke

Statistics

Publications

Citations

346

H-Index

Active since

2018

Affiliations

Institute of Cellular and Organismic Biology, Academia Sinica(Current)

Institute of Biomedical Sciences, Academia Sinica

Biomedical Translation Research Center

National Taiwan University

Institute of Biological Chemistry, Academia Sinica

Feng-Yi Ke is an author at Institute of Cellular and Organismic Biology, Academia Sinica specializing in cancer cell signaling, oncology, and molecular oncology.

Publications per year

2018–2023

Publications

ENO1 Promotes Lung Cancer Metastasis via HGFR and WNT Signaling–Driven Epithelial-to-Mesenchymal Transition

Hsin‐Jung Li, Feng-Yi Ke, Chia-Ching Lin et al. · Cancer Research · 2021 · 192 citations · Full text

Medicine, Cancer Biology, Oncology +17

Extracellular domain of EpCAM enhances tumor progression through EGFR signaling in colon cancer cells

Kang-Hao Liang, Hsien-Cheng Tso, Shao-Hsi Hung et al. · Cancer Letters · 2018 · 95 citations

Medicine, Molecular Biology, Oncology +11

Structure-guided antibody cocktail for prevention and treatment of COVID-19

Shih-Chieh Su, Tzu‐Jing Yang, Pei‐Yu Yu et al. · PLoS Pathogens · 2021 · 30 citations · Full text

Pharmacy, Infectious Disease Control, Infectious Diseases +17

Monoclonal antibodies against S2 subunit of spike protein exhibit broad reactivity toward SARS-CoV-2 variants

Shih-Han Ko, Shih-Chieh Su, Hsiu-Ting Lin et al. · Journal of Biomedical Science · 2022 · 15 citations · Full text

Pharmacy, Immunology, Infectious Diseases +11

Broadly neutralizing antibodies against Omicron variants of SARS-CoV-2 derived from mRNA-lipid nanoparticle-immunized mice

Ruei‐Min Lu, Kang-Hao Liang, Hsiao-Ling Chiang et al. · Heliyon · 2023 · 14 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

1–5 of 5